ProQR Therapeutics (PRQR) FCF Payout Ratio (2013 - 2025)
ProQR Therapeutics (PRQR) posted FCF Payout Ratio of 8.86 for Q3 2025, down 11.05% sequentially from 7.98 in Q1 2025, and up 46.78% YoY from 6.03 in Q3 2024.
ProQR Therapeutics (PRQR) FCF Payout Ratio (2013 - 2025) Analysis & Trends
ProQR Therapeutics has reported FCF Payout Ratio for 13 years, with the latest figure at 8.86 in Q3 2025.
- Quarterly FCF Payout Ratio rose 46.78% year-over-year to 8.86 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 7.34 (up 36.27% YoY) and the FY2021 annual result came in at 7.08, down 347.8% from the prior year.
- FCF Payout Ratio eased to 8.86 in Q3 2025 per PRQR's latest filing, from 7.98 in the prior quarter.
- Over five years, FCF Payout Ratio peaked at 41.06 in Q4 2021 and troughed at 19.81 in Q3 2021.
- A 5-year average of 6.56 and a median of 8.86 in 2025 frame the typical range for FCF Payout Ratio.
- The sharpest annual moves came in 2021 and 2024: FCF Payout Ratio surged 712.19% in 2021, then slumped 291.35% in 2024.
- Over 5 years, FCF Payout Ratio stood at 41.06 in 2021, then sank by 116.18% to 6.64 in 2022, then tumbled by 125.31% to 14.97 in 2023, then declined by 11.21% to 16.65 in 2024, then soared by 46.78% to 8.86 in 2025.
- According to Business Quant data, FCF Payout Ratio over the past three periods registered 8.86, 7.98, and 16.65 for Q3 2025, Q1 2025, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.17 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.07 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8.86 |
| Mar 31, 2025 | -7.98 |
| Sep 30, 2024 | -16.65 |
| Jun 30, 2024 | -11.06 |
| Mar 31, 2024 | -5.95 |
| Sep 30, 2023 | -14.97 |
| Jun 30, 2023 | -11.97 |
| Mar 31, 2023 | 3.11 |
| Sep 30, 2022 | -6.64 |
| Jun 30, 2022 | -10.70 |
| Mar 31, 2022 | -8.09 |
| Dec 31, 2021 | 41.06 |
| Sep 30, 2021 | -19.81 |
| Jun 30, 2021 | -14.05 |
| Mar 31, 2021 | -5.79 |
| Dec 31, 2020 | -6.71 |
| Sep 30, 2020 | -9.31 |
| Jun 30, 2020 | -8.59 |
| Mar 31, 2020 | -6.62 |
| Dec 31, 2019 | -9.55 |